资讯

The Sebi investigation follows a complaint alleging that PDCL’s slump sale is being executed at an artificially low valuation ...
In the high-stakes world of specialty retail, where trends are ephemeral and customer loyalty is hard-won, the gap between a ...
Sebi bars Par Drugs & Chemicals from slump sale to promoter-linked entity due to valuation and shareholder concerns.
SEBI has prohibited Par Drugs Chemicals from conducting a slump sale to a promoter-linked entity, highlighting regulatory compliance issues and protecting minority shareholder interests.
Point of Sale (POS) system developed in Java 21 with Spring Boot 3.2.0. This project implements a complete REST API for supermarket management, including sales, inventory, customers, employees, and ...
More than 18,000 Spotify users joined a group called Unwrapped, which set out with the goal of allowing said users to ...
Only show cars that can be delivered to me. Please enter your postal code in order to show cars that can be delivered to you.
Private equity company Permira is looking to offload its CDMO Cambrex in a sale that could value the latter company at up to ...
This is an experimental Python library for Anker Solix Power devices (Solarbank, Inverter, Smart Meter etc). Poetry 2.0.0 or later is required for full support of the ...
Sebi on Monday barred API manufacturer Par Drugs and Chemicals from going ahead with the proposed slump sale of its core business to a promoter-related entity, citing prima facie irregularities in ...